-
Recordkeeping and
Reporting Requirements for Drug Products Containing
Gamma-Hydroxybutyric Acid (GHB) (November 25, 2003)
-
Chemical Registration Waivers; Exemption From
Chemical Registration Fees for Certain Persons (November 25, 2003)
-
Sale by Federal Departments
or Agencies of Chemicals Which Could Be Used in the Illicit
Manufacture of Controlled Substances (November 6, 2003)
-
Proposed Rule: Preventing
the Accumulation of Surplus Controlled Substances at Long Term Care
Facilities (November 3, 2003)
-
Controlled Substances
Registration and Reregistration Application Fees (October 10,
2003)
-
Implementation of the Methamphetamine
Anti-Proliferation Act; Thresholds for Retailers and for Distributors
Required To Submit Mail Order Reports; Changes to Mail Order Reporting
Requirements (October 7, 2003)
-
Schedules of Controlled
Substances: Exempt Anabolic Steroid Products (September 12, 2003)
-
Proposed Rule: Exemption
From Import/Export Requirements for Personal Medical Use
(September 11, 2003)
-
Schedules of Controlled
Substances: Extension of Temporary Placement of N-Benzylpiperazine
(BZP), 1-(3- Trifluoromethylphenyl)piperazine (TFMPP) and
2,5-Dimethoxy-4-(n)- propylthiophenethylamine (2C-T-7) in Schedule I
of the Controlled Substances Act (September 10, 2003)
-
Establishment of a
Threshold for Gamma-Butyrolactone (September 10, 2003)
-
Notice of proposed
rulemaking. Schedules of Controlled Substances: Placement of
2,5-Dimethoxy-4- (n)-propylthiophenethylamine, N-Benzylpiperazine and
1-(3- Trifluoromethylphenyl)piperazine Into Schedule I of the
Controlled Substances Act (September 5, 2003)
-
Interim final rule with
request for comment. Definition and Registration of Reverse
Distributors (July 11, 2003)
-
Reports by Registrants of
Theft or Significant Loss of Controlled Substances (July 8, 2003)
-
Notice of proposed rulemaking. Electronic Orders for Controlled Substances
(June 27, 2003)
-
Control of Red Phosphorus, White Phosphorus and
Hypophosphorous Acid (and Its Salts) as List I Chemicals; Exclusions and
Waivers (June 24, 2003)
-
Allowing Central Fill
Pharmacies and Retail Pharmacies To Fill Prescriptions for Controlled
Substances on Behalf of Retail Pharmacies (June 24, 2003)
-
Authority for
Practitioners To Dispense or Prescribe Approved Narcotic (Opioid)
Controlled Substances for Maintenance or Detoxification Treatment
(June 24, 2003)
-
Schedules of Controlled
Substances: Exempt Anabolic Steroid Products - Suspension of interim
rule. (June 13, 2003)
-
Proposed Removal of
Fenfluramine From the Controlled Substances Act; Withdrawal of
Proposed Rule (May 15, 2003)
-
Proposed Rule: Sale by
Federal Departments or Agencies of Chemicals Which Could Be Used in
the Illicit Manufacture of Controlled Substances (May 8, 2003)
-
Exemption of Chemical Mixtures Containing the
List I Chemicals Ephedrine, N-Methylephedrine, N-Methylpseudoephedrine,
Norpseudoephedrine, Phenylpropanolamine, and Pseudoephedrine (May
1, 2003)
-
Schedules of Controlled
Substances: Temporary Placement of alpha-methyltryptamine and
5-methoxy-N,N-diisopropyltryptamine into Schedule I (April 4,
2003)
-
Privacy Act of 1974;
Implementation (March 24, 2003)
-
Clarification of Listing of
"Tetrahydrocannabinols''
in Schedule I (March 21, 2003)
-
Exemption From Control of
Certain Industrial Products and Materials Derived From the Cannabis
Plant (March 21, 2003)
-
Maintenance of
Records; Technical Correction (March 11, 2003)
-
Proposed Rule
- Controlled Substances Registration and
Reregistration Application Fees (February 18, 2003)
-
Chemical
Mixtures Containing Listed Forms of Phosphorus (January 31, 2003)
-
Proposed Rule
- Privacy Act of 1974; Implementation (January 27, 2003)
-
Schedules of Controlled Substances: Exempt
Anabolic Steroid Products (January 15, 2003)